In the 28-year history of Blue Cross conversions, no deal had come this close to the wire and walked
The first-line nod was backed by interim data from the Phase III COMMANDS trial, which pitted Reblozyl against the ESA standard of care treatment, Amgen and Johnson & Johnsons Epogen/Procrit
While Wegovy (semaglutide) has been shown to be effective for weight management and even beneficial for heart health in many patients, some people have reported experiencing heart palpitations or an increased heart rate while on the medication
Int J Mol Sci 2019;20:1341.ArticlePubMedPMC 58
Diabetes Care 2014: 37:2291-5
Typically, a BMI of 30 or higher, or a BMI of 27 or higher with additional weight-related health concerns such as high blood pressure, type 2 diabetes, or elevated cholesterol, may indicate that you could benefit from weight-loss medications like tirzepatide